Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation...
Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one...
Announced it has been selected by Mind Medicine, Inc to host a phase IIb randomized clinical trial investigating ...
Announces that it has granted an aggregate of 325,000 restricted share units ("RSUs") effective March ...
Today launched Healing Stories, a series of case studies with first-hand accounts of patient experiences ...
Announced an update to shareholders on a clinical pilot investigating the efficacy of group ketamine-assisted ...
Announced it is enrolling participants in a phase II clinical trial sponsored by Alto Neuroscience, ...
Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing...
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza TORONTO, ON / ACCESSWIRE / December 6, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"),...
TORONTO, ON / ACCESSWIRE / December 2, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will present...